Both venetoclax and S63845 exerted selective cytotoxicity against the tumor cells which highly expressed Bcl-2 or Mcl-1 protein, but had limited efficacy in tumor cells with low expression of Bcl-2 or Mcl-1 consistent with previous studies (25, 33, 34). The gene discussed is BCL2; the disease is neoplasm.